Vol 6, No 3 (2020)
Review paper
Published online: 2020-09-10
Page views 2929
Article views/downloads 58
Get Citation

Connect on Social Media

Connect on Social Media

Type I neurofibromatosis — clinical features and diagnosis

Karolina Krawczyk1, Marta Kołt-Kamińska1, Adam Reich12
Forum Dermatologicum 2020;6(3):67-72.

Abstract

Disorders in the embryonic development affecting three germ layers result in the formation of skin-muscular syndromes — phakomatoses. Type 1 neurofibromatosis (NF-1) is the most common phakomatosis. NF-1, also known as Recklinghausen’s disease, occurs at a frequency of 1:2500–1:3000, with equal distribution in males and females regardless of race, and is caused by mutations of the NF1 gene on the long arm of chromosome 17q11.2. This is an autosomal dominant disease with variable gene expression and incomplete penetration, resulting in variable clinical picture. Over 70% of patients are diagnosed between 5th and 18th year of age. Café-au-lait spots, neurofibromas, plexiform neurofibromas, skinfold freckling, optic nerve glioma, Lisch nodules and skeletal abnormalities are the most common symptoms. Café-au-lait spots occur in 99% of patients, but neurofibromas, which are tumors of the peripheral nerve sheaths, are the hallmark of this disease.

Article available in PDF format

Add to basket: 49.00 PLN

Aready have access?

References

  1. Ferner RE, Gutmann DH. Neurofibromatosis type 1 (NF1): diagnosis and management. Handb Clin Neurol. 2013; 115: 939–955.
  2. Corsello G, Antona V, Serra G, et al. Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1. Ital J Pediatr. 2018; 44(1): 45.
  3. National Institutes of Health Consensus Development Conference Statement. Neurofibromatosis. Archives of Neurology. 1988; 45(5): 575.
  4. Becker B, Strowd RE. Phakomatoses. Dermatol Clin. 2019; 37(4): 583–606.
  5. Antonio J, Goloni-Bertollo E, Tridico L. Neurofibromatosis: chronological history and current issues. Anais Brasileiros de Dermatologia. 2013; 88(3): 329–343.
  6. Troullioud Lucas AG, Mendez MD. Neurocutaneous syndromes. StatPearls. Last Update: August 10, 2020. Available at: https://www.ncbi.nlm.nih.gov/books/NBK537001/.
  7. Miettinen MM, Antonescu CR, Fletcher CDM, et al. Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview. Hum Pathol. 2017; 67: 1–10.
  8. Brenaut E, Nizery-Guermeur C, Audebert-Bellanger S, et al. Clinical characteristics of pruritus in neurofibromatosis 1. Acta Derm Venereol. 2016; 96(3): 398–399.
  9. Sałamacha M, Koseła H, Falkowski S, et al. Zespół von Recklinghausena (neurofibromatoza typu 1). Najczęstszy uwarunkowany genetycznie zespół prowadzący do powstawania mięsaków tkanek miękkich. Nowotwory. 2011; 61: 43–51.
  10. Rea D, Brandsema JF, Armstrong D, et al. Cerebral arteriopathy in children with neurofibromatosis type 1. Pediatrics. 2009; 124(3): e476–e483.